An Open Label Individual Patient Study Investigating the Safety and Efficacy of GCAR1 in a Patient with Metastatic Relapsed Alveolar Soft Part Sarcoma

Summary

This study is intended to understand if a new cancer therapy called GCAR1 is safe and effective in treating patients with metastatic cancer.

Eligibility

Currently recruiting participants: No

Eligible ages: 0 to 100

Inclusion criteria:

This study is only open to enroll a single patient who has already been identified.

Participate

Sorry, this study is not currently accepting new participants.
Browse other research studies.

Additional information

Contact information

djmahone@ucalgary.ca

Principal investigator:

Mona Shafey

Clinical trial:

Yes

REB-ID:

HREBA.CC-25-0218